Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing pancreatic β-cells are destroyed. Intestinal helminths can cause asymptomatic chronic and immunosuppressive infections and suppress disease in rodent models of T1D. However, the underlying regulatory mechanisms for this protection are unclear. Here, we report that CD8+ regulatory T (Treg) cells prevent the onset of streptozotocin -induced diabetes by a rodent intestinal nematode. Trehalose derived from nematodes affects the intestinal microbiota and increases the abundance of Ruminococcus spp., resulting in the induction of CD8+ Treg cells. Furthermore, trehalose has therapeutic effects on both streptozotocin-induced diabetes and in the NOD mouse model of T1D. In addition, compared with healthy volunteers, patients with T1D have fewer CD8+ Treg cells, and the abundance of intestinal Ruminococcus positively correlates with the number of CD8+ Treg cells in humans.
In type 1 diabetes (T1D), an autoimmune disease, insulin-producing pancreatic β-cells are destroyed, resulting in hyperglycaemia due to insulin insufficiency. Considering the recent increase of T1D in developed countries overwhelming rate of genetic changes, environmental factors appear to affect autoimmunity. One possible explanation for the involvement of environmental factors is the ‘hygiene hypothesis’, which suggests that reduced exposure to pathogens because of improved hygiene increases the risk of inflammatory disorders such as autoimmunity1,2. Among these pathogens, parasitic helminths can cause asymptomatic chronic infections and their absence is thought to be a contributor to the hygiene hypothesis3. Epidemiological and geographical evidence demonstrates the inverse correlation between helminthic manifestation and T1D prevalence4,5.
Intestinal helminthic infections are immunologically unique to induce type 2 responses as well as various regulatory immune responses to suppress host immunity for their survival within the hosts6,7,8. Animal models of T1D also support the ability of intestinal helminthic infections to prevent diabetes. Infection with Trichinella spiralis of non-obese diabetic (NOD) mice reduces onset of spontaneous development of diabetes by inducing dominant Th2 responses9. NOD mice infected with Heligmosomoides polygyrus (Hp) develop T1D to a lesser degree, and suppressive effects are not dependent on IL-10 or CD4+ Treg cells10. However, IL-10 is reported to have important functions in IL-4-deficient NOD mice11. This nematode also suppresses streptozotocin (STZ)-induced diabetes, and the protection is independent of IL-10 or Th2 polarisation through IL-4 signalling12. Aside from live helminth infection, several reports demonstrate that products and/or antigens derived from blood flukes and lymphatic filariae have the ability to suppress disease a in model of T1D13,14. However, such products have not been found in intestinal helminthic infections. Thus, molecular and cellular regulatory mechanisms underlying protection against T1D in intestinal helminthic infections are not clear.
As another environmental factor for increased prevalence of inflammatory disorders, recent studies indicate that the intestinal microbiota is associated with onset of some diseases. Human cohort studies demonstrate association between microbiota and T1D15, and animal models support the notion that microbiota is involved in T1D onset16,17. Given that intestinal helminthes affect composition of microbiota in mice18, protective effects of intestinal helminthes may be attributed to alteration of intestinal microbiota.
Here we show that a rodent intestinal nematode can prevent the onset of STZ-induced diabetes in a CD8+ regulatory T (Treg) cell-dependent manner. Infection with the nematode and its derivative, trehalose, affects the intestinal microbiota, resulting in the induction of CD8+ Treg cells. Ruminococcus spp. are more abundant in infected mice and seem to be responsible for induction of CD8+ Treg cells. Trehalose has a therapeutic effect not only in STZ-treated mice, but also in NOD mice. Furthermore, compared with healthy volunteers, patients with T1D have fewer CD8+ Treg cells and intestinal Ruminococcus.
Hp infection induces CD8+ Treg cells to prevent STZ-induced diabetes
Injection of C57BL/6 mice with multiple low doses of STZ resulted in hyperglycaemia and lower plasma insulin levels at 14 days after the first STZ administration (Fig. 1a, b). Immunohistochemical analyses revealed that these mice lost insulin-producing β-cells (Fig. 1c). Thus, as widely accepted19,20, the manipulation served as a model for autoimmune-mediated T1D. Mice infected with an intestinal nematode, Heligmosomoides polygyrus (Hp), at 2 weeks before T1D induction showed mild elevation of blood sugar and maintained insulin concentrations consistent with conservation of β-cells (Fig. 1a–c). These results demonstrate that infection with Hp protects mice from developing STZ-induced diabetes. Hp infection induces several immune suppressive cell types such as Foxp3+CD4+ regulatory T cells (CD4+ Treg cells) that suppress T1D in various settings21,22. Indeed, CD4+ Treg cells were increased in the spleen of mice infected with Hp (Supplementary Fig. 1a). However, these cells were not involved in the suppression of T1D observed in Hp-infected mice, because protective effects were not abolished in Hp-infected mice depleted of CD4+ Treg cells using an anti-CD25 antibody (Supplementary Fig. 1b).
We next examined CD8+ Treg cells identified as CD8+ T cells expressing CD122 (IL-2Rβ chain)23,24. As a result, Hp infection increased CD8+ Treg cells significantly in the pancreatic LN and spleen (Fig. 1d–f). Depletion of CD8+ Treg cells in Hp-infected mice by treatment with an anti-CD122 antibody completely reversed the protective effects of Hp infection against T1D (Fig. 1g–i). Although the depletion was not complete (with ~20% of these cells remaining), this depletion of CD8+ Treg cells was enough to prevent the onset of diabetes. However, the CD122+CD8− population that was also depleted by the anti-CD122 antibody might play a suppressive role in T1D development (Fig. 1f). To exclude this possibility, we performed a CD8+ Treg cells transfer experiment. Mice that received CD8+ Treg cells, but not CD122−CD8+ T cells, from Hp-infected mice did not exhibit blood glucose elevation (Fig. 1j). These results indicate that CD8+ Treg cells are responsible for the suppression of T1D. In addition, aged mice with more CD8+ Treg cells confirmed the involvement of CD8+ Treg cells in T1D suppression. As reported previously25, 60-week-old mice had substantially more CD8+ Treg cells in their spleen than young mice (Supplementary Fig. 2a). These aged mice were resistant to diabetes induction (Supplementary Fig. 2b, c), which depended on CD8+ Treg cells because aged mice depleted of CD8+ Treg cells developed diabetes comparable with young mice (Supplementary Fig. 2d).
Functionally, an in vitro T cell-suppression assay revealed that CD8+ Treg cells from Hp-infected mice remarkably suppressed the proliferation of CD4+ and CD8+ potential effector T cells in the presence of antigen-presenting cells in contrast to those from uninfected mice showing marginal suppression (Fig. 1k). In addition, CD8+ Treg cells showed a stronger ability to suppress interferon (IFN)-γ production crucial for the development of STZ-induced diabetes26 after Hp infection (Fig. 1l), indicating that Hp augments the suppressive functions of CD8+ Treg cells. This suppression may decrease IFN-γ-producing T cells in the pancreas of Hp-infected mice after T1D induction (Supplementary Fig. 3). Because CD8+ Treg cell addition regardless of the mouse origin increased the amount of IL-10 in culture supernatants, CD8+ Treg cells appear to secrete this anti-inflammatory cytokine (Fig. 1l). Nevertheless, the contribution of IL-10 to T1D suppression was limited (Supplementary Fig. 4).
Trehalose produced in Hp is crucial for diabetes suppression
In terms of the molecular mechanisms of CD8+ Treg cell induction, Hp-derived molecule(s) are hypothesised to modulate intestinal environments. To test this hypothesis, we comprehensively analysed intestinal contents by gas chromatography/mass spectrometry (GC/MS). Univariate analyses of 48 identified metabolites were performed, and a volcano plot demonstrated that trehalose, a disaccharide consisting of two glucose molecules, was the most remarkably increased after Hp infection (Fig. 2a). This disaccharide was the only metabolite increased significantly as assessed by Bonferroni’s method (Supplementary Table 1). Absolute quantification of trehalose in the intestinal contents was also performed using GC/MS. Identification of trehalose in biological samples by GC/MS is difficult because of its similarity to both the mass spectrum and retention time of methoximated maltose, a disaccharide consisting of two glucose molecules. Thus, trehalose and maltose with methoximation were analysed in detail and differentiated clearly (Supplementary Figs. 5, 6). Finally, a substantial amount of trehalose was observed in the intestinal contents of Hp-infected mice (Fig. 2b). The trehalose concentration in the serum of mice infected with Hp was significantly higher than that in uninfected mice (Fig. 2c), suggesting that trehalose is absorbed from the intestines. Furthermore, analysis of Hp excretory/secretory (HES) antigens collected from culture supernatants of adult worms revealed that the trehalose level was highly elevated among HES antigens (Fig. 2d, e). Three metabolites including trehalose were significantly increased among HES antigens (Supplementary Table 2), indicating that Hp produced and secreted trehalose in the intestines. In addition to adult worms, infective L3 larvae secrete trehalose. Fourier transform infra-red (FTIR) microscopic analyses revealed the location of concentrated trehalose as vesicle-like red signals along the worm body surface. Thus, a large amount of trehalose was detected in the preservative water containing L3 larvae (Supplementary Fig. 7a, b).
We next analysed whether Hp-derived molecules including trehalose contribute to diabetes suppression. Oral administration of HES antigens to mice increased CD8+ Treg cells and suppressed T1D onset (Fig. 2f, g). HES antigens treated with trehalase, which degrades trehalose, did not induce CD8+ Treg cells or suppress diabetes (Fig. 2f, g). Moreover, comparable with Hp infection, trehalose feeding induced CD8+ Treg cells, prevented blood sugar elevation, and preserved the insulin concentration. In contrast, mice fed with control sugar maltose remained susceptible to diabetes induction (Fig. 2h–j). These results indicate that trehalose derived from Hp is an important molecule in the induction of CD8+ Treg cells responsible for suppressing T1D.
To assess the therapeutic effect of trehalose, it was fed to STZ-treated mice and NOD mice after development of high blood glucose. Long-term feeding of trehalose suppressed the blood glucose elevation in STZ-treated mice significantly, but at lesser degree compared with Hp infection (Fig. 2k). Trehalose feeding to NOD mice with mild hyperglycaemia (<350 mg/dl) at the beginning of feeding completely reversed the glucose level increase (Fig. 2l). It is noteworthy that treatment with trehalose increased CD8+ Treg cells even in mice refractory to treatment (Fig. 2m). These results suggest that trehalose might be used to treat T1D treatment when regeneration of pancreatic β-cells is possible.
Intestinal microbiota contributes to diabetes suppression
Next, to determine whether the intestinal microbiota was involved in the CD8+ Treg cell induction, Hp-infected mice were orally administered an antibiotic mixture or ampicillin to perturb the microbiota prior to diabetes induction. Although these treatments did not affect Hp infection (Supplementary Fig. 8), CD8+ Treg cells were not increased in mice treated with antibiotics even in the presence of Hp infection (Fig. 3a), resulting in failure to suppress STZ-induced diabetes development in these mice (Fig. 3b). Thus, the microbiota is required for the CD8+ Treg cell induction crucial for diabetes suppression.
To find distinct characteristics in the microbiota inducing CD8+ Treg cells, we analysed the microbiota in the small intestines and faeces of mice infected with Hp and those fed with trehalose. Mice containing more CD8+ Treg cells had more genus Ruminococcus than control mice (Fig. 3d, e). We further examined the relationship between the amount of CD8+ Treg cells and faecal microbiota, and found that 12 and 7 genera were positively and negatively correlated, respectively. Among these 12 genera, the most highly correlated genus was Ruminococcus, an anaerobic and Gram-positive coccus (Fig. 3e). Real-time PCR confirmed that Hp-infected and trehalose-treated mice had more Ruminococcus species than untreated mice (Fig. 3f). In addition, increased intestinal Ruminococcus was observed in aged mice and NOD mice treated with trehalose containing more CD8+ Treg cells (Supplementary Fig. 9). These results strongly suggest that CD8+ Treg cells induction is correlated with the abundance of Ruminococcus.
To further establish the involvement of Ruminococcus in diabetes suppression and induction of CD8+ Treg cell, we attempted to isolate a single Ruminococcus species, OTU718, which was increased in mice fed with trehalose. However, it was impossible, presumably because of its requirements for strict nutrition and/or highly anaerobic conditions. Thus, we used the closest relative Ruminococcus gnavus among cultivable strains. As a control, we used Faecalibacterium prausnitzii identical to OTU58, belonging to the same family of Ruminococcaceae as OTU718 and unaffected by trehalose feeding (Fig. 3g, h). Feeding R. gnavus, but not F. prausnitzii, to STZ-treated mice significantly suppressed the blood glucose elevation (Fig. 3i). Furthermore, coculture of splenocytes from uninfected mice with supernatants from R. gnavus cultures increased CD8+CD122+ cells (Fig. 3j). These results indicate that these particular Ruminococcus species are, at least partially, responsible for the CD8+ Treg cell induction resulting in prevention of diabetes onset.
CD8+ Treg cells and gut microbiota in patients with T1D
We extrapolated our findings on the diabetes suppressive effect of CD8+ Treg cells in mice to humans. First, we analysed CD8+ Treg cells in peripheral blood obtained from children with T1D. Flow cytometric analyses demonstrated that T1D patients had fewer CD8+ Treg cells, defined as CD8+CD122+CXCR3+ cells27, than healthy volunteers (Fig. 4a, b). By contrast, there was no difference in the CD4+ Treg cell frequency (Supplementary Fig. 10). We also analysed the faecal microbiota of T1D patients and found lower ratios of the family Ruminococcaceae and genus Ruminococcus than in healthy volunteers (Fig. 4c, d). Moreover, the serum trehalose concentration in T1D patients was very low compared with that in healthy volunteers (Fig. 4e), and a highly positive correlation was found between the abundance of trehalose, CD8+ Treg cells, and Ruminococcus (Fig. 4f). These results suggest that CD8+ Treg cells suppress T1D development and that the gut microbiota, specifically Ruminococcus, augments CD8+ Treg cells in both humans and mice.
In this study, we clarified a novel mechanism underlying T1D suppression during Hp infection. Trehalose derived from Hp affects the microbiota, increasing Ruminococcus specifically, resulting in the induction of suppressive CD8+ Treg cells. Because trehalose is secreted from L3 larvae, its concentration is elevated immediately after infection and maintained at high levels during infection. Trehalose has cytoprotective effects and contributes to adaptations to harmful conditions in insects such as anhydrobiosis and cryptobiosis28,29. L3 larvae may produce trehalose to adapt to environmental fluctuations outside of the host body where they develop. Trehalose derived from Hp, in turn, exerts anti-diabetic effects through β-cell protection, which might be explained by its ability to induce CD8+ Treg cells.
Trehalose does not appear to directly induce CD8+ Treg cells, but indirectly induces them through an alteration of the intestinal microbiota. Because recent reports have demonstrated that specific bacteria induce specific T-cell subsets30,31,32, some bacteria may activate CD8+ Treg cells. Based on our results together with utilisation of trehalose as one of the assimilable sugars by Ruminococcus33, Ruminococcus is the most likely candidate.
Notably, our findings might be applicable to clinical situations. Compared with healthy individuals, patients with T1D have fewer CD8+ Treg cells in association with a smaller number of Ruminococcus and amount of trehalose. Our insights into the suppressive mechanisms of T1D may lead to prophylactic and therapeutic applications such as using trehalose and Ruminococcus strains as a prebiotic and probiotic, respectively, as well as cell transfer of autologous CD8+ Treg cells differentiated from induced pluripotent stem cells.
Male C57BL/6J mice purchased from Japan SLC Inc. and female NOD mice from CLEA Japan Inc. were maintained under specific pathogen-free conditions at 23 ± 2 °C, 55 ± 5% humidity with automated controlled 12 h dark/light cycle. Mice used for experiments at 8–10 or 60 weeks of age. All animal experiments were reviewed and approved by the Committee for Ethics on Animal Experiments at the Graduate School of Gunma University (approval number 16–041). Animal experiments were conducted in accordance with the Guidelines for Animal Experiments of the Graduate School of Gunma University, and the Low (No. 105) and Notification (No. 6) of the Japanese Government.
Heligmosomoides polygyrus infection
Hp were maintained in mice and serially passaged. For experimental infections, we used infectious L3 larvae obtained from eggs in the faeces of infected mice after culture on filter paper soaked in distilled water34. Mice were orally infected with 200 L3 larvae in 500 μl DW by gastric intubation. Establishment of infection was confirmed by detecting eggs in faeces.
Induction and evaluation of diabetes
C57BL/6J mice were intraperitoneally administered STZ (50 mg/kg body weight) for five consecutive days to induce diabetes, as described previously12. Blood samples were periodically collected from mice via puncture of the tail vein to monitor blood glucose concentrations using lab glucose cartridge and sensor devices (ForaCare Inc.). The determination of insulin levels in serum samples was performed by an LBIS mouse Insulin ELISA kit (AKRIN-011RU, Shibayagi Co. Ltd.), according to the manufacturer’s instructions.
Pancreatic tissues excised from mice after STZ administration were fixed in 4% paraformaldehyde and embedded in paraffin. Tissue sections (5-μm thick) were subjected to immunohistochemistry with a polyclonal guinea pig anti-insulin antibody (A0564, Dako) at 1:200 dilution. Stained areas were quantified using a BZ-8100 microscope (Keyence), NIS-Elements (Nikon), and ImageJ (NIH)35. At least 10 sections from individual mice were examined.
Single-cell suspensions of mouse spleens, mesenteric lymph nodes, pancreatic lymph nodes, and pancreatic tissues were incubated with an anti-CD16/32 (93; eBioscience) to block Fc receptors to prevent non-specific antibody binding and then stained with the following mAbs conjugated to fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), phycoerythrin-indotricarbocyanine (PE-Cy7), allophycocyanin-indotricarbocyanine (APC-Cy7), or PerCP-cy5/5 (eBioscience or BioLegend): anti-mouse CD4 (GK1.5), anti-mouse CD25 (PC61), anti-mouse CD8 (53-6.7), anti-mouse CD122 (TMβ-1), and anti-mouse IFN-γ (XMG1.2). Mononuclear cells separated from peripheral blood of T1D patients by gradient centrifugation using Ficoll-Hypaque (GE healthcare, Tokyo, Japan) were stained with fluorescent dye-conjugated anti-human CD4 (RPA-T4), anti-human CD25 (BC96), anti-human CD8 (SK1), anti-human CD122 (TU27), and anti-human CXCR3 (G025H7) antibodies. For intracellular staining, cells stained as described above were fixed and permeabilized with BD Cytofix/Perm (BD Bioscience) and then stained with anti-mouse Foxp3 (MF-14) or anti-human Foxp3 (259D) antibodies. All fluorescent antibodies were used at dilution 1/50. Stained cells were collected on FACSverse (BD Bioscience) and data acquired using FACSDiva (BD Bioscience). Data analysis was performed using FlowJo 9.1 software (Treestar). Gating strategies are shown in Supplementary Fig. 11.
In vivo cell depletion and cytokine neutralisation
To deplete cells expressing CD122 including CD8+ Treg cells in vivo, mice were injected with 500 μg anti-CD122 mAb (TMβ-1) or control isotype rat IgG at 1 and 3 days before and at 7 and 14 days after the first STZ administration. CD4+ Treg cells were depleted using the anti-CD25 (7D4) antibody as described above. For IL-10 neutralisation, mice were injected intraperitoneally with 500 μg anti-IL-10 monoclonal antibody (JES5-2A5) at −1, 0, 5, and 7 days after T1D induction.
Isolation and adoptive transfer of CD8+ Treg cells
Single-cell suspensions of spleens from Hp-infected mice were stained with fluorescent dye-conjugated anti-CD8 and anti-CD122 antibodies. CD8+CD122+ and CD8+CD122− cells were sorted by a FACSAria II (BD Bioscience). The sorted cells were at least 98% pure. Five hundred thousand purified cells were intravenously transferred into uninfected recipient mice at 1 day before STZ administration.
In vitro T cell-suppression assay
Briefly, purified splenic CD4+CD25− or CD8+CD122− responder cells from uninfected mice were labelled using a CellTrace Violet kit (Thermo Fisher). The cells were then cocultured with sorted CD8+ Treg cells from uninfected or Hp-infected mice with or without antigen-presenting cells (splenic CD3−CD8− cells) from uninfected mice in the presence of a plate-bound anti-CD3 antibody (2C11) for 3 days. Cells were harvested and analysed by flow cytometry. Labelled cells with diluted fluorescence were considered as proliferative cells. Cytokines in supernatants of cell cultures were also analysed using ELISA kits (R&D Systems), according to the manufacturer’s instructions.
Contents in the small intestines of mice were collected in Eppendorf tubes on ice and then weighed. Then, 250 μl of a solvent mixture (MeOH:H2O:CHCl3 = 2.5:1:1) and 5 μl of 1 mg/ml 2-isopropylmalic acid (2-IPM) (Sigma-Aldrich) as an internal standard were added to the tube. The mixture was vortexed for 30 min at room temperature before centrifugation at 21,000×g for 5 min at room temperature. The supernatant (225 μl) was transferred to a new tube, and 200 μl of water was added to the tube. After vortexing, the tube was centrifuged at 21,000×g for 5 min at room temperature, and 250 μl of the supernatant was transferred to a new tube and stored in a freezer before use. The supernatant (50 μl) was transferred to a new tube and lyophilised using a centrifugal concentrator. For oximation, 40 μl pyridine with or without 20 mg/ml methoxyamine hydrochloride (Sigma-Aldrich) was added to the lyophilised sample. The tube was sonicated to disperse the lyophilised powder before shaking at 1400 rpm for 90 min at 30°C. Then, 20 μl N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA) (GL Science) was added for derivatization. The mixture was then incubated at 37 °C for 30 min with shaking at 1400 rpm. The tube was centrifuged at 21,000×g for 5 min at room temperature, and 1 μl of the resultant supernatant was injected into a DB-5 capillary column (30 × 0.25 mm; film thickness: 1 μm) (Agilent Technologies). In addition, GC/MS analysis was performed using a GCMS-TQ8030 (Shimadzu) equipped with an AOC-20i autosampler (Shimadzu).
Analysis of small molecular weight metabolites was performed based on Smart Metabolites Database Release 3.01 (Shimadzu) that contains the data acquisition parameters for 571 compounds in full-scan mode and 467 compounds in multiple reaction monitoring (MRM) mode. Data acquisition was performed in both full-scan and MRM modes. GC–MS solution software Version 4.41 (Shimadzu) was used for data processing. Retention time correction was performed based on the retention time of a standard n-alkane mixture (Restek). The peaks were assigned automatically and checked manually. For comparison between samples from control and infected mice, each peak area was normalised based on the weight of intestinal contents and the peak area of 2-IPM. Statistical analysis was performed using the two-tailed unpaired Student’s t-test. p-values were adjusted by Bonferroni’s method and the Benjamini–Hochberg method.
Measurement of trehalose
Trehalose measurement was performed in L3 larval samples and human sera using a trehalose assay kit (#K-TREH, Magazyme), according to the manufacturer’s instructions.
Preparation of HES antigens
Adult worms collected from the small intestines of Hp-infected mice were washed extensively in sterile PBS containing penicillin and streptomycin (Gibco), and 200 worms were cultured in 1 ml DMEM (Sigma-Aldrich) containing penicillin and streptomycin for 3 days. The supernatant was collected as HES antigens. In some experiments, trehalase (Sigma-Aldrich) was added to HES antigens at 0.025 U/ml, followed by incubation overnight at 37 °C36.
For antibiotic treatments, mice were treated with the following combination of antibiotics (ABX): ampicillin (1 g/l), metronidazole (1 g/l), vancomycin (500 mg/l), and neomycin (1 g/l), or ampicillin (1 g/l) alone (Amp) in drinking water for 14 days.
Mice were fed 3% trehalose in drinking water for 7 days before STZ treatment or 500 μl HES antigens with or without trehalose exposure by gastric intubation for 7 days.
The FTIR measurements of infected L3 larvae of Hp were performed according to a previous study on the larvae of an African chironomid37. The whole body of larvae was sandwiched between two KBr plates. Lattice mapping spectra in the 4000–750 cm−1 range were collected by an infra-red microscope (IRT-7200 with FT/IR-6600 spectrometer; JASCO) equipped with a liquid nitrogen-cooled, mercury-cadmium-telluride, 16-element, linear array detector. Sequential spectra were collected at 570 points (15 × 38 points) in the specimen. For each spectrum, 32 interferograms were collected, signal averaged, and Fourier transformed to generate spectra with a spectral resolution of 8 cm−1, pixel resolution of 12.5, and pixel resolution of 12.5 signal averaged, and Fourier transformed to generate spectra with a spectral resolution of 8 interferograms.
16S rRNA gene pyrosequencing
Faecal and small intestinal samples collected from mice were immediately frozen in liquid nitrogen and stored at −80 °C. Faecal DNA extraction was performed according to a previous study38 with minor modifications. A grain of mouse faeces or human faecal pellets were suspended with sterilised sticks in 475 μl TE10 buffer containing 10 mM Tris-HCl (pH 8.0) and 10 mM EDTA. The faecal suspension was incubated with 15 mg/ml lysozyme (Wako) at 37 °C for 1 h. A final concentration of 2000 U/ml purified achromopeptidase (Wako) was then added, followed by incubation at 37 °C for 30 min. Then, 1% (wt/vol) sodium dodecyl sulfate and 1 mg/ml proteinase K (Merck Japan) were added to the suspension, followed by incubation at 55 °C for 1 h. After centrifugation, bacterial DNA was purified using a phenol/chloroform/isoamyl alcohol (25:24:1) solution. The DNA was precipitated by adding ethanol and sodium acetate. RNase A (Wako) was added to bacterial DNA in TE buffer to a final concentration 1 mg/ml. To remove fragmented low molecular weight DNA, polyethylene glycol (PEG 6000) precipitation was performed after RNase treatment.
The V4 variable region (515F–806R) was sequenced on an Illumina MiSeq, following the method of Kozich et al.39 Each reaction mixture contained 15 pmol of each primer, 0.2 mM deoxyribonucleoside triphosphates, 5 μl of 10× Ex Taq HS buffer, 1.25 U Ex Taq HS polymerase (Takara), 50 ng extracted DNA, and sterilised water to reach a final volume of 50 μl. PCR conditions were as follows: 95 °C for 2 min, 25 cycles of 95 °C for 20 s, 55 °C for 15 s, and 72 °C for 1 min, followed by 72 °C for 3 min. The PCR product was purified by AMPure XP (Beckman Coulter) and quantified using a Quant-iT PicoGreen ds DNA Assay Kit (Life Technologies Japan). Mixed samples were prepared by pooling approximately equal amounts of PCR amplicons from each sample. The pooled library was analysed with an Agilent High Sensitivity DNA Kit on an Agilent 2100 Bioanalyzer (Agilent Technologies). Real-time PCR for quantification was performed on the pooled library using a KAPA Library Quantification Kit for Illumina, following the manufacturer’s protocols. Based on the quantification, the sample library was denatured and diluted. A sample library with 20% denatured PhiX spike-in was sequenced by MiSeq using a 500-cycle kit. We obtained 2 × 250 bp paired-end reads. The sequence data were processed using Quantitative Insights into Microbial Ecology software (QIIME, v1.8.0) and Mothur v. 1.36.140.
Real-time quantitative PCR
Bacterial genomic DNA was isolated from faecal pellets using a QIAamp Stool Mini Kit (Qiagen). DNA encoding 16S rRNA was quantified by SYBR Green dye incorporation (Takara) analysed using an ABI Prism 7700 thermal cycler and detector system (Thermo Fisher Scientific)41. qPCR was carried out according to the manufacturers’ instructions. The PCR primer sequences used to universally amplify 16S rRNA of all bacteria were 5′-GTGCCAGCMGCCGCGGTAA-3′ and 5′-GACTACCAGGGTATCTAAT-3′. The sequences used to specifically amplify 16S rRNA of Ruminococcus were 5′-CTAGGTGAAGATACTGACGGTAACCTG-3′ and 5′-GTATTACCGCGGCTGCTGGCAC-3′42. The relative amount of Ruminococcus to whole bacteria was calculated based on the difference in the threshold cycle between universal and specific PCR products.
Ruminococcus gnavus (JCM6515), the closest species to OTU718, and Faecalibacterium prausnitzii (JCM 31915) identical to OTU58 were obtained from the RIKEN BioResource Research Center. Both bacteria were cultivated in YCFA medium43. The media were centrifuged and separated into precipitates and supernatants. To adjust the concentration, the precipitates were diluted with PBS, resulting in an OD 600 of approximately 0.8 (4 × 108 CFU). Supernatants were passed through membrane filters with a 0.2-μm pore size (Sartorius) and diluted to adjust the concentration in accordance with the OD 600 of precipitates before use.
Colonisation of bacteria and bacterial stimuli of T cells
R. gnavus and control bacteria F. prausnitzii were grown overnight, and then ~1 × 108 CFU in 200 µl YCFA medium was orally administered to B6 mice at 14 days after diabetes induction for 5 days. Blood glucose levels in the mice were analysed each week. For in vitro experiments, splenocytes (1 × 105) from uninfected mice were incubated with supernatants from the bacterial cultures at a medium:supernatant ratio of 4:1. All cultures were performed in triplicate wells containing 200 µl complete RPMI medium (RPMI 1640 containing 2 mM l-glutamine and 25 mM HEPES) supplemented with 10% FBS for 2 days.
The Ethics Committee of the Graduate School of Medicine, Gunma University approved all human experiments conducted in this study (approval number 2016-071). Nineteen patients and 16 healthy volunteers were enroled. Informed consent was obtained from the parents of participating children and/or participants. The clinical characteristics of the patients are summarised in Supplementary Table 3. Blood samples from newly diagnosed patients were collected at the inpatient department, and samples from well-controlled patients were collected at the outpatient department. All faecal samples were collected in tubes containing RNAlater (Sigma-Aldrich) within 3 days before or after blood collection and stored at 4 °C until analysis.
All statistical analyses were performed using Prism software with the two-tailed unpaired Student’s t-test or one-way ANOVA, followed by Tukey’s post-hoc test or two-tailed Mann–Whitney test. p-values of <0.05 were considered as significant (*p < 0.05, **p < 0.01, and ***p < 0.001).
Sequence data are available at DDBJ with the accession code PRJDB9558. The authors declare that the other data underlying the figures and Supplementary Information in this manuscript are available from the authors on reasonable request.
Bach, J. F. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat. Rev. Immunol. 18, 105–120 (2018).
Okada, H., Kuhn, C., Feillet, H. & Bach, J. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin. Exp. Immunol. 160, 1–9 (2010).
Gale, E. A. M. A missing link in the hygiene hypothesis? Diabetologia 45, 588–594 (2002).
Zaccone, P. & Hall, S. W. Helminth infection and type 1 diabetes. Rev. Diabet. Stud. 9, 272–286 (2012).
Aravindhan, V. et al. Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. Am. J. Trop. Med. Hyg. 83, 1336–1339 (2010).
McSorley, H. J. & Maizels, R. M. Helminth infections and host immune regulation. Clin. Microbiol. Rev. 25, 585–608 (2012).
Moreau, E. & Chauvin, A. Immunity against helminths: interactions with the host and the intercurrent infections. J. Biomed. Biotechnol. 2010, 428593 (2010).
Maizels, R. M. & Hewitson, J. P. Myeloid cell phenotypes in susceptibility and resistance to helminth parasite infections. Microbiol. Spectr. 4, MCHD-0043-2016 (2016). https://doi.org/10.1128/microbiolspec.MCHD-0043-2016.
Saunders, K. A., Raine, T., Cooke, A. & Lawrence, C. E. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect. Immun. 75, 397–407 (2007).
Liu, Q. et al. Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms. Infect. Immun. 77, 5347–5358 (2009).
Mishra, P. K., Patel, N., Wu, W., Bleich, D. & Gause, W. C. Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response. Mucosal Immunol. 6, 297–308 (2013).
Osada, Y. et al. Heligmosomoides polygyrus infection reduces severity of type 1 diabetes induced by multiple low-dose streptozotocin in mice via STAT6- and IL-10-independent mechanisms. Exp. Parasitol. 135, 388–396 (2013).
Zaccone, P. et al. Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J. Biomed. Biotechnol. 2010, 795210 (2010).
Hubner, M. P. et al. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-beta. J. Immunol. 188, 559–568 (2012).
Giongo, A. et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5, 82–91 (2011).
Wen, L. et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455, 1109–1113 (2008).
Markle, J. G. M. et al. Gammadelta T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model. J. Immunol. 190, 5392–5401 (2013).
Walker, A. W. et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5, 220–230 (2011).
Muller, A., Schott-Ohly, P., Dohle, C. & Gleichmann, H. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiol. 205, 35–50 (2002).
Paik, S. G., Blue, M. L., Fleischer, N. & Shin, S. Diabetes susceptibility of BALB/cBOM mice treated with streptozotocin. Inhibition by lethal irradiation and restoration by splenic lymphocytes. Diabetes 31, 808–815 (1982).
Finney, C. A. M., Taylor, M. D., Wilson, M. S. & Maizels, R. M. Expansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infection. Eur. J. Immunol. 37, 1874–1886 (2007).
Aravindhan, V. et al. Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. Am. J. Trop. Med. Hyg. 83, 1336–1339 (2010).
Akane, K., Kojima, S., Mak, T. W., Shiku, H. & Suzuki, H. CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity. Proc. Natl Acad. Sci. USA 113, 2460–2465 (2016).
Endharti, A. T. et al. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J. Immunol. 175, 7093–7097 (2005).
Rifa’i, M., Kawamoto, Y., Nakashima, I. & Suzuki, H. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J. Exp. Med. 200, 1123–1134 (2004).
Herold, K. C. et al. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J. Immunol. 156, 3521–3527 (1996).
Shi, Z. et al. Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. Eur. J. Immunol. 39, 2106–2119 (2009).
Erkut, C., Gade, V. R., Laxman, S. & Kurzchalia, T. V. The glyoxylate shunt is essential for desiccation tolerance in C. elegans and budding yeast. eLife 5, e13614 (2016).
Watanabe, M., Kikawada, T. & Okuda, T. Increase of internal ion concentration triggers trehalose synthesis associated with cryptobiosis in larvae of Polypedilum vanderplanki. J. Exp. Biol. 206, 2281–2286 (2003).
Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).
Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013).
Obata, Y. et al. The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells. Nat. Immunol. 15, 571–579 (2014).
Crost, E. H. et al. Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. PLoS ONE 8, e76341 (2013).
Shimokawa, C. et al. Mast cells are crucial for induction of group 2 innate lymphoid cells and clearance of helminth infections. Immunity 46, 863–874.e864 (2017).
Kikuchi, O. et al. FoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularization. PLoS ONE 7, e32249 (2012).
Johnston, C. J. C. et al. Cultivation of Heligmosomoides polygyrus: an immunomodulatory nematode parasite and its secreted products. J. Vis. Exp. 6, e52412 (2015).
Sakurai, M. et al. Vitrification is essential for anhydrobiosis in an African chironomid, Polypedilum vanderplanki. Proc. Natl Acad. Sci. USA 105, 5093–5098 (2008).
Atarashi, K. et al. Th17 Cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367–380 (2015).
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112–5120 (2013).
Myer, P. R., Kim, M., Freetly, H. C. & Smith, T. P. Evaluation of 16S rRNA amplicon sequencing using two next-generation sequencing technologies for phylogenetic analysis of the rumen bacterial community in steers. J. Microbiol. Methods 127, 132–140 (2016).
Wang, I. K. et al. Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients. Appl. Environ. Microbiol. 78, 1107–1112 (2012).
Fuhrer, A. et al. Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J. Exp. Med 207, 2843–2854 (2010).
Browne, H. P. et al. Culturing of ‘unculturable’ human microbiota reveals nove taxa and extensive sporulation. Nature 533, 543–546 (2016).
We thank Ms. Wakana Mizutani for technical assistance, Dr. Osamu Kikuchi (Metabolic Signal Research Center, Institute of Molecular and Cellular Regulation, Gunma University) for preparing pancreatic sections, and Mr Ken-ichi Akao and Taro Takami (JASCO Corporation) for assistance with FTIR imaging. We are sincerely grateful to all of the T1D patients and healthy volunteers who participated in this study. We also thank Mitchell Arico from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. This work was supported by a Grant-in-Aid for International Scientific Research (B) from the Japan Society for the Promotion of Science (15H05274 to H.H.), Grants-in-Aid for Scientific Research (B) (16H05207 to H.O.) and (C) (15K08441 and JP19K07530 to H.H.), and Early career scientists (19K16682 to C.S.) from the Ministry of Education, Culture, Sports, Science, and Technology, the Japan Agency for Medical Research and Development (JP19fk018096 to H.H.), The Food Science Institute Foundation to H.O., Core Research for Evolutional Science and Technology (JP18gm0710009 to H.O.), Grants provided by the Ichiro Kanehara Foundation Japan, Takeda Science Foundation, Naito foundation, Yakult Bio-Science Foundation, Shiseido Female Researcher Science Grant, The Nakajima Foundation, and Uehara Memorial Foundation to C.S.
The authors declare no competing interests.
Peer review information Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shimokawa, C., Kato, T., Takeuchi, T. et al. CD8+ regulatory T cells are critical in prevention of autoimmune-mediated diabetes. Nat Commun 11, 1922 (2020). https://doi.org/10.1038/s41467-020-15857-x
This article is cited by
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Nature Reviews Immunology (2023)
Oral administration of asparagine and 3-indolepropionic acid prolongs survival time of rats with traumatic colon injury
Military Medical Research (2022)
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
BMC Cancer (2022)
Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes
Nature Communications (2022)
The role of berberine in Covid-19: potential adjunct therapy
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.